- Filed
- Aug 7, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Jul 31, 2020 | 113.98M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 115.91M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2020 | 119.4M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 118.29M sh |
| Shares Diluted restated | Q2 2020 · Jun 30, 2019 | 123.48M sh |
| Stock Repurchased | Q2 2020 · Jun 30, 2020 | $39.37M |
| Stock Repurchased | Q2 2020 · Jun 30, 2019 | $71.27M |
| Capex | Q2 2020 · Jun 30, 2020 | $235K |
| Capex | Q2 2020 · Jun 30, 2019 | $163K |
| Cash And Equivalents | Q2 2020 · Jun 30, 2020 | $105.45M |
| Cash And Equivalents | Q2 2020 · Dec 31, 2019 | $168.98M |
| Stockholders Equity | Q2 2020 · Jun 30, 2020 | $420.47M |
| Stockholders Equity | Q2 2020 · Dec 31, 2019 | $593.2M |
| Stockholders Equity | Q2 2020 · Mar 31, 2019 | $693.78M |
| Stockholders Equity | Q2 2020 · Dec 31, 2018 | $729.78M |
| Current Liabilities | Q2 2020 · Jun 30, 2020 | $36.24M |
| Current Liabilities | Q2 2020 · Dec 31, 2019 | $45.69M |
| Total Liabilities | Q2 2020 · Jun 30, 2020 | $100.66M |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $123.93M |
| Current Assets | Q2 2020 · Jun 30, 2020 | $495.55M |
| Current Assets | Q2 2020 · Dec 31, 2019 | $313.9M |
| Total Assets | Q2 2020 · Jun 30, 2020 | $520.66M |
| Total Assets | Q2 2020 · Dec 31, 2019 | $717.21M |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | −$0.43 |
| Eps Diluted | Q2 2020 · Jun 30, 2020 | −$0.68 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | −$0.04 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | $0.02 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | −$0.43 |
| Eps Basic | Q2 2020 · Jun 30, 2020 | −$0.68 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | −$0.04 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | $0.02 |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $9.72M |
| Sga Expense | Q2 2020 · Jun 30, 2020 | $22.47M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $8.7M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $17.01M |
| Rd Expense | Q2 2020 · Jun 30, 2020 | $1.47M |
| Rd Expense | Q2 2020 · Jun 30, 2020 | $3.32M |
| Rd Expense | Q2 2020 · Jun 30, 2019 | $886K |
| Rd Expense restated | Q2 2020 · Jun 30, 2019 | $1.8M |
| Net Income | Q2 2020 · Jun 30, 2020 | −$49.97M |
| Net Income | Q2 2020 · Jun 30, 2020 | −$81.69M |
| Net Income | Q2 2020 · Jun 30, 2019 | −$4.42M |
| Net Income | Q2 2020 · Jun 30, 2019 | $2.26M |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$13.76M |
| Operating Income | Q2 2020 · Jun 30, 2020 | −$45.52M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | −$9.26M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | −$17.47M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2020 | $2.64M |
| Cost Of Revenue | Q2 2020 · Jun 30, 2020 | $5.5M |
| Cost Of Revenue restated | Q2 2020 · Jun 30, 2019 | $4.93M |
| Cost Of Revenue restated | Q2 2020 · Jun 30, 2019 | $8.73M |
| Stock Issued | Q2 2020 · Dec 31, 2019 | 13.4M sh |